新天药业: 2025年第一次临时股东会法律意见

Core Viewpoint - The legal opinion from Beijing Deheng Law Firm confirms the legality of the 2025 First Extraordinary General Meeting of Guizhou Xintian Pharmaceutical Co., Ltd, stating that all procedures and voting results comply with relevant laws and regulations [1][8]. Group 1: Meeting Procedures - The meeting was convened on July 10, 2025, with the board approving the proposal to hold the extraordinary general meeting [3]. - The notice for the meeting included details such as the convenor, meeting format, time, location, and agenda [3][4]. - The meeting utilized a combination of on-site voting and online voting, with specific time slots for both [3][4]. Group 2: Participant Qualifications - A total of 10 shareholders and their proxies attended the meeting, representing 81,180,341 shares, which is 33.2565% of the total shares [4]. - An additional 107 shareholders participated via online voting, representing 1,116,510 shares, or 0.4574% of the total shares [4]. Group 3: Voting Procedures and Results - All voting matters were clearly outlined in the meeting notice, and no items were postponed or omitted from voting [5][8]. - The voting results for key proposals showed overwhelming support, with the proposal to increase registered capital receiving 99.9705% approval [6][7]. - The election of non-independent and independent directors also received high approval rates, with votes exceeding 98.84% for most candidates [7][8].